Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assay

Item

http://www.wikidata.org/entity/Q36313615

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Comparison of phenotypically i ...... um bactericidal antibody assay

@ast

Comparison of phenotypically i ...... um bactericidal antibody assay

@en

type

Item

label

Comparison of phenotypically i ...... um bactericidal antibody assay

@ast

Comparison of phenotypically i ...... um bactericidal antibody assay

@en

prefLabel

Comparison of phenotypically i ...... um bactericidal antibody assay

@ast

Comparison of phenotypically i ...... um bactericidal antibody assay

@en

P1476

Comparison of phenotypically i ...... um bactericidal antibody assay

@en

P2093

Ann Holland

http://www.w3.org/2001/XMLSchema#string

Franklin Sotolongo

http://www.w3.org/2001/XMLSchema#string

Jamie Findlow

http://www.w3.org/2001/XMLSchema#string

Jan Poolman

http://www.w3.org/2001/XMLSchema#string

Nick Andrews

http://www.w3.org/2001/XMLSchema#string

Paul Balmer

http://www.w3.org/2001/XMLSchema#string

Vincent Weynants

http://www.w3.org/2001/XMLSchema#string

P2860

Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.

Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine.

Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit.

Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.

The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.

Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.

Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine.

Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac

Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.

Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine

P304

1451-1457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00195-07

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ray Borrow

P577

2007-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17881507

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria meningitidis

P932

2168179

http://www.w3.org/2001/XMLSchema#string